Literature DB >> 19736185

World Health Organization Class III COPD-associated pulmonary hypertension: are we there yet in understanding the pathobiology of the disease?

M Kathryn Steiner1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19736185     DOI： 10.1378/chest.09-0896

Source DB:  PubMed          Journal:  Chest        ISSN： 0012-3692            Impact factor:   9.410


× No keyword cloud information.
  2 in total

1.  Decreased neprilysin and pulmonary vascular remodeling in chronic obstructive pulmonary disease.

Authors:  Marilee J Wick; Erica J Buesing; Carol A Wehling; Zoe L Loomis; Carlyne D Cool; Martin R Zamora; York E Miller; Sean P Colgan; Louis B Hersh; Norbert F Voelkel; Edward C Dempsey
Journal:  Am J Respir Crit Care Med       Date:  2010-09-02       Impact factor: 21.405

2.  Deficiency of Akt1, but not Akt2, attenuates the development of pulmonary hypertension.

Authors:  Haiyang Tang; Jiwang Chen; Dustin R Fraidenburg; Shanshan Song; Justin R Sysol; Abigail R Drennan; Stefan Offermanns; Richard D Ye; Marcelo G Bonini; Richard D Minshall; Joe G N Garcia; Roberto F Machado; Ayako Makino; Jason X-J Yuan
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2014-11-21       Impact factor: 5.464
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.